Treatment of in-stent restenosis remains a therapeutic challenge. Twenty-seven lesions with in-stent restenosis were treated with non-polymer-based paclitaxel-eluting stents. At 6-month follow-up, in-stent late loss was 0.44 +/- 0.54 mm and the restenosis rate was 20%, indicating effective treatment for reduction of recurrent restenosis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.amjcard.2003.12.006 | DOI Listing |
Publication Analysis
Top Keywords
in-stent restenosis
12
treatment in-stent
8
restenosis
5
restenosis stent
4
stent non-polymer-based
4
non-polymer-based paclitaxel
4
paclitaxel elution
4
elution treatment
4
restenosis remains
4
remains therapeutic
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!